Syngene International Q1 Results
- BSE: 539268
- NSE: SYNGENE
- ISIN: INE398R01022
- Sector: Biotechnology & Drugs
BSE
445.50
-3.70 (-0.82%)
-3.70 (-0.82%)Volume72.85 K
Updated: Tue 9 Jun, 2026 | 15:29:58
NSE
444.30-5.20 (-1.16%)
-5.20 (-1.16%)Volume1.23 M
Updated: Tue 9 Jun, 2026 | 15:30:02
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Quarter ended Jun 25
Note: Comparison is on QoQ basis
Quarterly - Syngene International Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 25 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 774.50 | 829.50 | -0.18% | 691.50 | 12.00% |
| Depreciation/ Amortization | 111.20 | 111.50 | 4.81% | 106.90 | 4.02% |
| Operating Income | 100.00 | 207.00 | -58.69% | 98.20 | 1.83% |
| Net Income | 86.70 | 147.90 | -52.70% | 75.70 | 14.53% |
| Other Operating Expenses Total | 184.00 | 178.10 | 1.21% | 153.20 | 20.10% |
| Net Income Before Taxes | 101.30 | 196.00 | -57.88% | 101.30 | 0.00% |
| Total Revenue | 874.50 | 1,036.50 | -14.10% | 789.70 | 10.74% |
| Selling/ General/ Admin Expenses Total | 261.70 | 300.80 | 3.44% | 229.90 | 13.83% |
| Diluted Normalized EPS | 2.15 | 3.78 | -52.58% | 1.29 | 67.17% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.